Senate bill seeks to curb US reliance on China in drug industry

US lawmakers are pushing for more scrutiny of Chinese investment in pharmaceuticals and biotechnology, as Washington’s strategic competition with Beijing expands beyond semiconductors and artificial intelligence into the healthcare sector. Bipartisan US senators on Wednesday unve